Stem Cells Ease Stroke-Like Brain Damage in Mice

The strategy might someday help humans recover from similar events, scientists say

By Amanda Gardner
HealthDay Reporter

Related Encyclopedia • Alzheimer's Disease • Aneurysms • Angina Pectoris • Angiogram More... Related Healthscout Videos Hungry Heart Challenging Mortality Stem Cell Solutions Prime Time More... Related Animations • Alzheimer's Disease Video Animation • Angioplasty • Coronary Bypass Surgery • Erectile Dysfunction More... Related Drug Information • Accupril • Actonel • Altace • Avapro More... Related News Articles • Family Issues Translate Into Sick Days at Work • Ankle Circulation Could Warn of Future Strokes • Surgery Better Than Angioplasty for Narrowed Neck Artery • Steady Improvements Seen for Young Blood Cancer Patients More...

MONDAY, Sept. 15 (HealthDay News) -- Human stem cells derived from bone marrow can cut the brain damage caused by an interruption in blood supply, such as what happens after a heart attack, scientists report.

Although these initial results were seen in mice, researchers are hopeful the breakthrough will one day help humans struck by cardiac arrest or stroke.

Text Continues Below

---

The human cells did not trigger the development of new brain cells, as previously believed. Instead, they switched on and off different genes, essentially turning down inflammation and immune system reactions that were harmful to the brain.

"This is the first time that interactions between the two kinds of cells [injected cells and host cells] worked out," said Dr. Darwin Prockop, senior author of the study, which appears in this weeks issue of the Proceedings of the National Academy of Sciences.

The study was completed while Prockop was with Tulane University's Center for Gene Therapy. He recently accepted a post as Stearman Chair in Genomic Medicine at Texas A&M Health Science Center College of Medicine and is director of the Institute for Regenerative Medicine at Scott & White.

"The big thing was finding out how these cells were helping," Prockop elaborated. "This dramatic crosstalk was very surprising. The human cells specifically turned down immune and inflammatory reactions."

The finding "goes along with the argument that something here could be used in human therapy. Even though this is a short-term fix, it might be sufficient to have a reparative function," added Dr. Robert Schwartz, director of the Texas A&M Health Science Center Institute of Biosciences and Technology, in Houston.

For this study, Prockop's team at Tulane injected human mesenchymal stromal cells (hMSCs) into the brains of adult mice one day after blood flow to the rodents' brains had been temporarily blocked.

Page:  1 | 2 | Next >>